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Edited by Michael R. BubbAbstract Progenitor cells may contribute to cardiac regenera-
tion. Here, we investigated the role of cadherins and integrins
for diﬀerentiation of human adult circulating endothelial progen-
itor cells (EPCs) into cardiomyocytes (CM) in a co-culture sys-
tem. N- and E-cadherin were expressed in EPCs and were
localized at the interface between EPCs and CM. Incubation
of a blocking antibody against E-cadherin reduced the expres-
sion of CM marker protein in EPCs. Blocking antibodies against
N- or P-cadherin or the b1- and b2-integrins were not eﬀective.
These data suggested that cell-to-cell communication mediated
by E-cadherin contributes to the acquirement of a cardiomyo-
genic phenotype of human endothelial progenitor cells.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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A number of cardiovascular diseases such as myocardial
infarction lead to cardiomyocyte loss and consequently deteri-
oration of cardiac function. The replacement of cardiomyo-
cytes by cell therapy would be a promising option to
regenerate cardiac tissue. Furthermore, the transplantation
of healthy stem cells may compensate for mutated, dysfunc-
tional genes in cardiomyocytes as suggested by ﬁrst animal
studies [1]. Several diﬀerent types of adult stem and progenitor
cells have been shown to diﬀerentiate into the cardiomyogenic
lineage. Bone marrow-derived hematopoietic stem cells, mes-
enchymal stem cells and side population (SP)-cells showed
expression of cardiac marker proteins after infusion in animal
models of myocardial infarction [2–4]. Additionally, tissue res-
ident cardiac progenitor cells have been identiﬁed [5,6], which
can diﬀerentiate into cardiomyocytes. Very recent studies ques-
tioned that c-kit+/lin bone marrow-derived stem cells can ac-
quire a cardiac phenotype after injection in a mouse model of
acute myocardial infarction [7,8]. Moreover, other studies sug-
gested that bone marrow-derived stem cells can fuse with*Corresponding author. Fax: +49 69 6301 7113/6374.
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both fusion and diﬀerentiation occur in mice after injection
of cardiac stem cells in a model of myocardial infarction [6].
The reason for the controversial outcomes between the studies
is not yet resolved and likely reﬂects methodological diﬀer-
ences.
In order to determine the molecular mechanism(s) underlying
cardiomyogenic diﬀerentiation of adult stem or progenitor
cells, we used a co-culture system of neonatal rat cardiomyo-
cytes to mimic the cardiac environment [10]. Embryonic endo-
thelial cells [10], human CD34+ cells [11], and human peripheral
blood mononuclear cell-derived circulating endothelial progen-
itor cells (EPCs) [12] were shown to acquire a cardiomyogenic
phenotype after co-culture. In this co-culture assay, expression
of cardiac genes and Gap-junctional communication between
neonatal cardiomyocytes and diﬀerentiating stem or progenitor
cells was detected [10,12]. Functional activity of the diﬀerenti-
ated circulating progenitor cells was documented by showing
oscillating calcium transients after pacing [12]. These data sug-
gest that the co-culture system might be useful as an experimen-
tal model system to study the mechanism(s) of cardiomyogenic
diﬀerentiation of adult progenitor cells.
Interestingly, albeit at a lower extent cardiac diﬀerentiation
was still achieved, when paraformaldehyde-ﬁxed cardiomyo-
cytes were used as matrix for the co-culture assay [12], but
was not observed by co-incubation with cardiomyocyte-condi-
tioned medium [10,12] suggesting an important role of cell-to-
cell or cell-to matrix interaction for cardiac diﬀerentiation.
Cellular interactions can be mediated by integrins or cadher-
ins. Particularly, b1-integrin expression was shown to be essen-
tial for the diﬀerentiation of cardiac muscle cells from
embryonic stem cells [13]. Cadherins are also known to regu-
late signaling processes such as diﬀerentiation, proliferation,
and migration [14]. Among the classic cadherins, which are cal-
cium dependent and have ﬁve repeats of cadherin-speciﬁc
extracellular modules, N-cadherin and E-cadherin are crucial
for cardiogenesis [15,16]. N-cadherin deﬁciency resulted in car-
diovascular defects [15]. Forced N-cadherin or E-cadherin
expression using a- or b-MHC promotor rescued the heart
development in N-cadherin null mice [16], demonstrating
an essential role of cadherins in embryonic cardiogenesis.
Moreover, connexin 43-mediated Gap-junctional intercellular
communication is regulated by E-cadherin [17]. We had previ-
ously reported that adhesion of EPCs to ﬁxed cardiomyocytesblished by Elsevier B.V. All rights reserved.
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cium-dependent proteins such as integrins or cadherins for
cell-to-cell communication between EPC and cardiomyocytes.
Here, we investigated the contribution of integrins and cad-
herins for the acquirement of a cardiomyogenic phenotype of
EPCs after co-culture with neonatal cardiomyocytes. Our
data demonstrate an important role of E-cadherin on EPCs
diﬀerentiation. In particular, E-cadherin blocking antibody
signiﬁcantly inhibited the expression of the cardiac marker
a-sarcomeric actinin in the human EPCs after co-culture. In
contrast, inhibition of N- or P-cadherin and integrin blocking
experiments had no eﬀect. Furthermore, addition of an E-
cadherin blocking antibody did not aﬀect cell fusion, suggest-
ing a predominant role of E-cadherin on EPC diﬀerentiation.2. Materials and methods
2.1. Antibodies and peptides for cell culture
Anti-N-cadherin antibody (Ab) (clone NCD-2), anti-E-cadherin Ab
(clone HECD-1), anti-P-cadherin Ab (clone NCC-CAD-299) were pur-
chased from Calbiochem (San Diego, CA). Anti-integrin b1 antibody
(clone P4C10) was obtained fromChemicon (Temecula, CA). Anti-inte-
grin b2 (CD18) Ab was purchased from Cymbus Biotechnology (UK).
RGD peptide (H-Gly-Arg-Gly-Asp-Asn-Pro-OH; GRGDNP) and
RGD control peptide (H-Gly-Arg-Gly-Glu-Ser-Pro-OH; GRGESP)
were from Bachem. N-cadherin blocking peptide (sequence: RAD-
SFDINGNQV) and control peptide (sequence: RAHAVDINGNQV)
were sythesized by Biosyntan (Berlin, Germany). The eﬃciency of this
peptides was conﬁrmed previously [18]. All antibodies and peptides were
incubated with EPC before co-cultivating and re-added every 2 days.
2.2. Cell culture experiments
Neonatal ventricular cardiomyocytes were isolated from 0 to 1 day
old Wistar rats and cultivated as previously described [12]. Noncardio-
myocytes (primarily ﬁbroblasts) were separated from the cardiomyo-
cytes by diﬀerential plating onto plastic dishes. EPCs were cultivated
from human peripheral blood mononuclear cells from healthy volun-
teers as described [12]. After 3 days in culture, adherent cells were
labeled with Dil-ac-LDL. EPCs have been extensively characterized
in our laboratory in previous studies [19]. Expression of endothelial
markers, such as vWF, KDR, and eNOS were routinously conﬁrmed
[12]. EPCs were pre-incubated with antibodies or isotype IgG for
30 min. Then EPCs (1.5 · 105) and freshly isolated cardiomyocytes
were plated onto gelatin coated dishes at a ratio of 1:3 [12]. In some
experiments, we ﬁxed cardiomyocytes with 2% paraformaldehye as de-
scribed [12]. Then, EPCs were added onto ﬁxed cardiomyocytes.
2.3. Immunostaining and ﬂow cytometry analysis
After 6 days of the co-culture, cells were stained with phycoerythrin-
conjugated antibodies recognizing human HLA-DR and HLA-class I
(both Caltag Laboratories, Burlingame, CA) followed by permeabili-
zation using the Cytoﬁx/Cytoperm kit (BD Pharmingen) and staining
with FITC-conjugated (Pierce, Rockford, IL) anti-a-sarcomeric acti-
nin antibody (clone EA-53, Sigma) as described [12]. 20000 cells were
analyzed on a BD FACS Calibur cell sorter (BD Biosciences, San Jose,
CA).
For immunostaining, cells were ﬁxed with PLP buﬀer (2% parafor-
maldehyde, 0.01 M NaIO4, 0.075 M lysine, 0.037 M phosphate buﬀer,
pH 7.2) for 15 min on ice. After permeabilization with 0.2% saponin
(Sigma), cells were incubated with pan-cadherin antibody (Sigma), fol-
lowed by staining with a FITC-conjugated anti-rabbit IgG (Jackson)
and a-sarcomeric actinin antibody (Sigma), followed by staining with
Cy5-conjugated anti-mouse IgG (Jackson). Nuclei were counterstained
with Sytox Blue (Molecular Probes) according to the manufactures
protocol.
2.4. RNA isolation and RT-PCR analyses
Total RNA from HUVEC, EPCs, and human heart were isolated by
using TRIzol (Invitrogen). RNA was subjected to RT-PCR by using
M-MLV Reverse Transcriptase (Invitrogen). Primers are as following:E-cadherin (5 0-GAACACAGGAGTCATCAGTGTGG-3 0/5 0-CTGC-
TACGTGTAGAATGTACTGC-3 0), N-cadherin (5 0-GCAAGACTG-
GATTTCCTGAAG-3 0/5 0-CTGGAGTTTTCTGGCAAGTTG-3 0),
H-cadherin (5 0-TGCGGAAGATATGGCAGAACTCG-3 0/5 0-GAGT-
TTTGCCATTGACATCAGTGG-3 0), VE-cadherin (5 0-AGGTATG-
AGATCGTGGTGGAAGC-3 0/5 0-TGGATGTATTCATAATCCAG-
AGGC-3 0), cadherin-19 (5 0-ATGCTGACGATCCCTCAAGTGG-3 0/
5 0-TCATCCTCTTCAATGCTGTAATCC-30), eNOS (5 0-CCAGCT-
AGCCAAAGTCACCAT-3 0/5 0-GTCTCGGAGCCATACAGGATT-
30), KDR (50-GGTGCACTGCAGACAGATCTACG-30/50-GTCGTC-
TGATTCTCCAGGTTTCC-30), GAPDH (50-TCACCATCTTCCAG-
GAGCGAGATC-30/50-GAGACCACCTGGTGCTCAGTGTAG-30).
2.5. Detection of cell fusion
Adenoviruses coding for enhanced GFP were generated by using
pAdTrack-cytomegalovirus and pShuttle-cytomegalovirus (provided
by Vogelstein [20]). One day after isolation cardiomyocytes were in-
fected with adenoviruses (MOI 20). Three days after the infection
cardiomyocytes were subsequently used for co-cultivation with Dil-
ac-LDL labeled EPCs. GFP+ cardiomyocytes were counted by immu-
nostaining. After 6 days of cultivation, cells were collected and subjected
to FACS analysis. GFP+/Dil-ac-LDL+ cells were deﬁned as fused cells.
We replated co-cultured cells at day 6 onto dishes with lower concentra-
tion to detect the cells on a single cell level. Then we performed immu-
nostaining as described above.
2.6. Statistical analysis
Data are expressed asmeans ± S.E.M.Unpaired, two-tailed Students
t-test was used for the comparison between groups based on the original
data.3. Results
Diﬀerentiation of EPCs into cardiomyocytes was induced by
co-incubation of EPCs with neonatal rat cardiomyocytes.
After 6 days of co-culture, the expression of the cardiac marker
protein a-sarcomeric actinin in the human cells was detected
by FACS staining against a-sarcomeric actinin and human
HLA. The cardiac phenotype of the EPCs was further con-
ﬁrmed by confocal microscopy showing expression of the car-
diac markers ANP and MEF-2, RT-PCR directed against
ANF and bMHC using human speciﬁc primers, and the dem-
onstration of oszillating calcium transients after pacing of the
human cells (see our previous publications [12,21]). Moreover,
the expression of the cardiac marker protein a-sarcomeric ac-
tinin was also detected when ﬁxed cardiomyocytes were co-cul-
tured with human EPCs (Fig. 1A, and [12]).
3.1. b1 and b2 integrins are not required for cardiac
diﬀerentiation of circulating endothelial progenitor cells
Since b1-integrins are essential for diﬀerentiation of embry-
onic stem cells into cardiomyocytes [13], we determined the
contribution of b1-integrin to the co-culture-induced diﬀeren-
tiation of human EPCs. Therefore, blocking antibodies
(10 lg/ml) or RGD peptides (0.5 mM) were added to the co-
culture of EPCs and neonatal cardiomyocytes and expression
of the cardiac marker a-sarcomeric actinin was determined
after 6 days. However, cardiac diﬀerentiation of EPCs was
not aﬀected by the b1-blocking antibody or RGD peptide
(Fig. 1B). Surprisingly, the survival and adhesion of EPCs in
the presence of b1-integrin blocking antibody or RGD peptide
was increased (Fig. 1C) suggesting that the blockade of b1-
integrins improves adhesion and survival but does not interfere
with diﬀerentiation. Next, we tested the eﬀects of b2-integrin
blocking antibodies. In the presence of b2-integrin antibodies,
the total number of human HLA positive cells was signiﬁ-
Fig. 1. (A) Representative immunocytochemical picture after 6 days co-culture of human Dil-ac-LDL EPC (red ﬂuorescence) with paraformal-
dehyde (2%) ﬁxed cardiomyocytes. The cardiac marker a-sarcomeric actinin was detected by using a FITC-conjugated antibody (green ﬂuoresence).
Nuclei are stained in blue. (B) Integrin antibodies (b1 integrin; 10 lg/ml, b2 integrin; 1 lg/ml) or RGD peptide (0.5 mM) were incubated with the
co-culture for 6 days and EPC diﬀerentiation was detected by FACS analysis. Isotype IgG and RGD control peptide were used as control. (n = 6).
(C) EPCs survival was determined by counting the number of total human HLA positive cells by FACS analysis. N = 5–6, \P < 0.05 versus control.
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drastic reduction of EPC adhesion and survival, the total num-
ber of double positive cells was not changed (64.2 ± 13.7 vs
76.7 ± 23.2; n = 5, out of 20000 total cells, respectively). Con-
trol experiments conﬁrmed that b1-, and b2-integrin blocking
antibodies eﬃciently and selectively blocked the respective
integrins [22].
3.2. Expression and functional contribution of cadherins
Since integrin blocking antibodies had no eﬀect on EPC dif-
ferentiation, we determined the expression of cadherins in the
co-culture system by confocal microscopy. Cadherins were
speciﬁcally expressed at the border between cardiomyocytes
and neighbouring EPCs (Fig. 2A: yellow arrow). Interestingly,
the non-diﬀerentiated human cells, which do not express the
cardiac marker protein a-sarcomeric actinin, did lack the spe-
ciﬁc staining of cadherins at the border to the cardiomyocytes
(Fig. 2A: white arrow). Next, we assessed the speciﬁc expres-
sion of cadherins in cardiomyocytes and EPCs by using RT-
PCR. As previously described, cardiomyocytes express N-cad-
herin (Fig. 2B). Additionally expression of E-cadherin was
documented in human heart (Fig. 2B). EPC expressed various
diﬀerent cadherin genes including E-cadherin, N-cadherin, andVE-cadherin. In contrast, H-cadherin and Cad-19 were only
expressed in human heart but were low to absent in EPC
(Fig. 2C). Interestingly, E-cadherin expression was signiﬁ-
cantly higher in EPC (424 ± 69.8%, P = 0.004) compared to
human umbilical venous endothelial cells, which lack the pro-
genitor cell characteristics (Fig. 2B).
In order to assess whether cadherins are essential for EPC
diﬀerentiation, we used cadherin blocking antibodies. E-cad-
herin blocking antibodies alone signiﬁcantly inhibited the
EPC diﬀerentiation, whereas N- and P-cadherin antibodies
had no eﬀect on EPC diﬀerentiation (Fig. 3A). The mixture
of N-, P-, E-cadherin blocking antibodies inhibited EPC diﬀer-
entiation but did not further signiﬁcantly reduce expression of
the cardiac marker protein a-sarcomeric actinin as compared
to E-cadherin antibodies (Fig. 3A). Since N-cadherin plays
an essential role in embryonic heart development, we con-
ﬁrmed the negative results obtained with the N-cadherin
blocking peptides by using a previously described peptide with
a sequence speciﬁc for the extracellular domain of N-cadherin
[18]. However, N-cadherin blocking peptides did not exert any
eﬀect (Fig. 3C). Control experiments showed that the survival
of EPC was similar in the diﬀerent antibody treatment regi-
mens (data not shown).
Fig. 2. Expression of Cadherins. (A) Representative immunocytochemical picture after 6 days of the co-culture. Human EPCs were labeled by Dil-
ac-LDL (red) and cardiomyocytes were detected by a-sarcomeric actinin (green). Pan-cadherin expression is shown in white. Nuclei are stained in
blue. Representative confocal images from n = 5 experiments are shown. Pan-cadherin was expressed at the border between cardiomyocytes and
neighbouring EPCs (yellow arrow). Non-diﬀerentiated human cells (white arrow), which do not express a-sarcomeric actinin, lack the speciﬁc
staining of cadherins at the border to the cardiomyocytes. Bar indicates 100 lm. (B/C) Expression of cadherins was detected in human umbilical
venous endothelial cells (HUVEC), three diﬀerent donor-derived EPC preparations (EPC A, EPC B, and EPC C), human heart. The endothelial NO-
synthase (eNOS), the VEGF-receptor-2 (KDR) and von Willebrand factor (vWF) were used as endothelial markers. Gene expressions were
controlled by GAPDH. ‘‘-RT’’ indicates samples without addition of reverse transcriptase. A representative ﬁgure out of N = 3–6 individual
experiments is shown.
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Because some investigators suggested the involvement of fu-
sion in the process of transformation of stem/progenitor cells
into cardiomyocytes, we tested whether cadherin blocking
antibodies could inhibit cellular fusion. For detecting fusion,
cardiomyocytes were transduced with an adenovirus coding
for GFP for 1 week and were then co-cultured for 6 days with
Dil-ac-LDL labeled EPCs. Importantly 98.8 ± 1.24% of the
cardiomyocytes did express GFP 1 week after transduction.
After 6 days of co-culture, cells positive for a-sarcomeric acti-
nin, GFP and Dil-ac-LDL were considered as fused cells,
whereas cells only positive for a-actinin and Dil-ac-LDL but
negative for GFP represent diﬀerentiated EPCs. Since GFP
and Dil-ac-LDL are not transported via Gap junctions,
GFP+/Dil-ac-LDL+ cells may only derive from cellular fusion
or transmembrane fusion allowing the exchange of organelles
and/or proteins. Using this criterion, fusion was observed in
2.9 ± 6% of the human cells, whereas 6.0 ± 0.7% of the cellswere positive for human HLA and a-sarcomeric actinin at
day 6 [21]. Thus, fusion represents roughly 50% of the cells
with cardiomyogenic phenotype. However, cadherin blocking
antibodies in the same concentration as used in the previous
experiments did not aﬀect the number of GFP+/Dil-ac-LDL+
fused cells, suggesting that E-cadherin speciﬁcally contributed
to EPCs diﬀerentiation but not to cell fusion (Fig. 3D).4. Discussion
The data of this study disclose an important role of E-cad-
herin for EPC diﬀerentiation into cardiomyocytes. Cadherin
expression was conﬁrmed by immunocytochemistry and RT-
PCR. Blocking experiments using an E-cadherin antibody sig-
niﬁcantly inhibited EPC diﬀerentiation, but not fusion of EPC
with cardiac myocytes. Although integrin b1 was essential for
the diﬀerentiation of cardiac muscle cells from embryonic stem
Fig. 3. (A/B) Cadherin blocking antibodies (10 lg/ml each) were incubated with the co-culture of human EPC and neonatal rat cardiac myocytes.
After 6 days of co-culture, FACS analysis was performed to detect the expression of the cardiac marker gene a-sarcomeric actinin in the human
HLA-positive cells. Isotype control IgG was used as control (n = 5). \P < 0.05 versus control IgG. Panel B shows a representative FACS analysis
after incubation of the co-culture with anti N-, E-, P-cadherin antibodies (10 lg/ml each). Upper right (blue box), indicates a-sarcomeric actinin and
human HLA double positive cells. (C) The eﬀect of N-cadherin blocking peptide (sequence: RADSFDINGNQV) on a-sarcomeric actinin expression
after 6 days of co-culture as assessed by FACS analysis. A control peptide (sequence: RAHAVDINGNQV) was used as a negative control. n = 8
experiments. D: Eﬀect of mixture of N-, E-, P-cadherin antibodies (10 lg/ml each) on cell fusion. Cardiac myocytes were transduced with an
adenovirus encoding GFP. After 1 week, cardiac myocytes were extensively washed and were co-incubated with Dil-ac-LDL labeled human EPC.
Double positive cells expressing GFP and show Dil-ac-LDL represent fused cells. n = 3 experiments. (E) Representative immunostaining of fused cell
and non-fused diﬀerentiated cell. Co-cultured cells of Dil-ac-LDL (red) labeled EPCs and GFP-transduced CM (green) were replated in a low density
to detect cells on a single cell level. Double positive cells for Dil-ac-LDL (red) and a-sarcomeric actinin (blue) were detected in GFP positive (green
arrow) and GFP negative cells (blue arrow). Nuclei are stained in white. Representative confocal images from n = 3 experiments are shown.
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diﬀerentiation in the co-culture system.
Classic cadherins promote calcium-dependent cell-to-cell
adhesion [23]. Furthermore, cadherins are also known to reg-
ulate diverse signaling processes such as diﬀerentiation, prolif-
eration, and migration [14]. Since adhesion of EPCs to ﬁxed
cardiomyocytes was calcium dependent [12], we hypothesized
that classic calcium-dependent cadherins were involved in
cell-to-cell communication between EPCs and cardiomyocytes.
Indeed, cadherins were expressed at the border between diﬀer-
entiated EPCs and cardiomyocytes (Fig. 2A). As classic cad-herins such as N-cadherin and E-cadherin are crucial for
cardiogenesis [15–17], we examined the eﬀect of N-, E-, and
P-cadherin blocking antibodies on EPC diﬀerentiation. Sur-
prisingly, only the blockade of E-cadherin signiﬁcantly inhib-
ited the expression of cardiomyocyte markers in human
EPCs. Cardiomyocytes predominantly express N-cadherin.
And it is not entirely clear, whether cardiomyocytes express
substantial amounts of E-cadherin. Thus, E-cadherin may be
potentially activated by heterophilic interactions [24].
Intracellular signaling of classic cadherins is mainly medi-
ated via b-catenin. b-catenin is a transcription cofactor of T
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lation of b-catenin by glycogen synthase kinase 3b (GSK3b)
leads to ubiquitination of b-catenin and its subsequent degra-
dation [23]. Activation of cadherins blocks the degradation of
b-catenin by inhibiting GSK3b activity [23]. However, we have
recently observed that inhibition of GSK3b by LiCl did not
aﬀect EPC diﬀerentiation [21]. These data suggested that the
signaling of EPC diﬀerentiation is unlikely to be mediated
via the GSK3b/b-catenin pathway. If so, how does cadherin
contribute to GSK3b/b-catenin-independent signal transduc-
tion? Recently, it had been reported that presenilin-1 cleaved
the N-cadherin intracellular domain resulting in degradation
of the transcriptional coactivator CREB binding protein [25].
E-cadherin could also be cleaved by cellular stress [26] or
presenilin-1 [27]. One may speculate that a C-terminal cleavage
fragment of E-cadherin might directly inﬂuence the intracellu-
lar signaling independent on b-catenin. However, we could not
detect a E-cadherin cleavage fragment by Western blot analy-
sis in the co-cultured cells under the condition tested (data not
shown). Thus, additional mechanisms appear to be mediated
by E-cadherin.
Recently, some investigators questioned that bone marrow-
derived hematopoietic stem cells can acquire a cardiac pheno-
type in vivo [7,8]. Moreover, other studies suggested that bone
marrow-derived stem cells can fuse with cardiomyocytes [9].
However, at least in vitro, stem/progenitor cells are capable
to diﬀerentiate into other lineages after co-culturing with ﬁxed
cells as shown in previous studies [12,28], thus indicating that
diﬀerentiation certainly exists. Furthermore, both fusion and
diﬀerentiation were shown to occur in mice after injection of
cardiac stem cells in a model of myocardial infarction [6].
We also conﬁrmed that fusion processes (either cellular or
transmembrane fusion) existed in our co-culture assay repre-
senting roughly 50% of a-sarcomeric actinin-positive EPCs.
However, E-cadherin blocking antibodies did not aﬀect fusion.
Thus, E-cadherin appears to rather selectively contribute to
EPC diﬀerentiation but not fusion.
Surprisingly, only E-cadherin did aﬀect EPC diﬀerentia-
tion. Of note, the E-cadherin expression pattern is diﬀerent
from other cadherins, when EPCs were compared with ma-
ture endothelial cells (HUVEC) (Fig. 2B). E-cadherin expres-
sion was signiﬁcantly higher in EPCs compared to HUVEC
(0.85 ± 0.07 vs 0.21 ± 0.04, P < 0.05, n = 3), whereas other
cadherins such as N-cadherin and VE-cadherin were prefer-
entially expressed in mature endothelial cells. In contrast to
a previous study showing a transdiﬀerentiation of freshly
isolated HUVEC to cardiomyocyte [10], cultivated HUVEC
(>3 passages) used in the present study failed to acquire a
cardiomyogenic phenotype (data not shown). Thus, it is pos-
sible that the selective expression of E-cadherin in progenitor
cells compared to HUVEC might contribute to the capacity
of the progenitor cells to acquire a cardiomyogenic pheno-
type.
Taken together, the present study describes that E-cadherin,
but not P-, N-cadherin as well as b1 or b2 integrins contributes
to the expression of cardiacmarker proteinswithin humanEPCs
after co-culture with neonatal rat cardiomyocytes. E-cadherin
blocking antibodies signiﬁcantly inhibited EPC diﬀerentiation
but not fusion, suggesting that cell-to-cell communication via
E-cadherin is involved in diﬀerentiation processes rather than
cell fusion.Acknowledgments: We thank Iris Stu¨gelmaier and Christine Goy
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